Considerations of pharmacogenetic testing in children-Reference-Cited by-同舟云学术

Considerations of pharmacogenetic testing in children

Published:2016-06 Issue:9 Volume:17 Page:975-977
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Haga Susanne B¹,Solomon Benjamin D²

Affiliation:

1. Department of Medicine, Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, 304 Research Drive, Box 90141, Durham, NC 27708, USA

2. Division of Medical Genomics, Inova Translational Medicine Institute, Associate Professor, Virginia Commonwealth University School of Medicine, 3300 Gallows Road, 2nd Floor, Claude Moore Building, Falls Church, VA 22042, USA

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0073

Reference20 articles.

1. Drug prescriptions to outpatient children: a review of the literature

2. Pharmacogenomics and active surveillance for serious adverse drug reactions in children

3. Pharmacogenomics and adverse drug reactions in children

4. Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parental understanding and attitudes following pharmacogenomic testing for pediatric neuropsychiatric patients;Pharmacogenomics;2022-04

2. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting;JAMA Network Open;2021-05-26

3. Collaborative Counseling Considerations for Pharmacogenomic Tests;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2017-08-07